# Nessan Bermingham

> Nessan Bermingham, Ph.D., is a serial biotech entrepreneur and Operating Partner at Khosla Ventures who has co-founded eight biotechnology companies including Intellia Therapeutics - one of the first public CRISPR gene editing companies - which he built from concept to IPO in under two years. A child of an Irish Army officer raised on a military base in Co. Kildare, he traded academia for Wall Street, Wall Street for venture capital, and venture capital for founding the companies reshaping genetic medicine. Today he shepherds a portfolio of cutting-edge biotech companies at Khosla Ventures while pursuing 155-mile ultra-marathons and aspiring to race at Dakar.

- **Role:** Operating Partner at Khosla Ventures
- **Organizations:** Khosla Ventures, Korro Bio, Triplet Therapeutics, Intellia Therapeutics, Amide, Bionaut Labs, Deep Genomics, Kamau Therapeutics, Liberate Bio, Ochre Bio, Stylus Biomedicine, Everyone Medicines, Atlas Venture, Omega Fund Management
- **From:** Cork, Ireland
- **Nationality:** Irish
- **Education:** B.S., Queen's University Belfast, Ph.D. in Molecular Biology, Imperial College London, Howard Hughes Associate Fellowship, Baylor College of Medicine
- **Known for:** Co-founded Intellia Therapeutics, one of the first public CRISPR gene editing companies, taking it from concept to IPO in under two years, Co-founded 8+ biotechnology companies across gene editing, RNA editing, and cell therapy, Completed a 155-mile self-supported ultra-marathon

## Career timeline

- **Early career** — Published paper in Science; realized academia was not his path
- **Early 2000s** — Joined UBS equity research team, covering life sciences
- **Post-9/11** — Left banking to pursue new challenges; joined Atlas Venture as venture partner
- **2009** — Deepened investment career; managed investments across US and Europe at Omega Fund Management
- **2012** — Led Tal Medical as CEO (medical device company spun from Harvard Medical School)
- **2014** — Co-founded Intellia Therapeutics; Intellia named Top-10 Biotech Startup of 2014
- **2016** — Took Intellia Therapeutics public (NASDAQ: NTLA) within two years of founding
- **2017** — Departed as President and CEO of Intellia Therapeutics
- **2019** — Co-founded Triplet Therapeutics with $59M launch financing; focused on Huntington's and repeat expansion disorders
- **2020** — Co-founded Korro Bio, RNA editing company using ADAR enzyme and OPERA platform
- **2023** — Korro Bio merged with Frequency Therapeutics, began trading on NASDAQ as KRRO; Bermingham became Chairman
- **2024+** — Joined Khosla Ventures as Operating Partner focused on life sciences, gene/cell therapy, nucleic acid editing
- **2025** — Stylus Medicine launches with $85M, with Bermingham as board member; named Vice Chair of BIO Investment Council

## Achievements

- Co-founded Intellia Therapeutics, one of the first public CRISPR gene editing companies, taking it from concept to IPO in under two years
- Co-founded 8+ biotechnology companies across gene editing, RNA editing, and cell therapy
- Completed a 155-mile self-supported ultra-marathon
- Obtained motorbike license at age 49
- Won a racing truck trophy at age 51
- Named Operating Partner at Khosla Ventures, one of Silicon Valley's most influential VC firms
- Vice Chair of the BIO Investment Council
- Former advisory board member at California Institute of Regenerative Medicine (CIRM)
- Intellia Therapeutics named Fierce 15 Top Biotech Company and Top-10 Biotech Startup in 2014

## Latest updates

- **2025-05** — Stylus Medicine launched with $85M in financing, with Bermingham serving as board member (Khosla Ventures is a lead investor)
- **2025-05** — Named Vice Chair of the BIO Investment Council, part of the Biotechnology Innovation Organization's new initiative to accelerate capital formation
- **2024-09** — Continues as Operating Partner at Khosla Ventures, overseeing life science portfolio companies
- **2023-11** — Korro Bio completed merger with Frequency Therapeutics and began trading on NASDAQ as KRRO with Bermingham as Chairman

## Links

- Website: https://www.khoslaventures.com/team/nessan-bermingham
- LinkedIn: http://www.linkedin.com/in/nessan-bermingham-b1254621b

---

Profile page: https://yespress.io/nessan-bermingham
Published by YesPress — https://yespress.io
Last updated: 2026-05-09